Search by Drug Name or NDC
NDC 65219-0432-85 Sodium Chloride 9 mg/mL Details
Sodium Chloride 9 mg/mL
Sodium Chloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is SODIUM CHLORIDE.
Product Information
| NDC | 65219-0432 |
|---|---|
| Product ID | 65219-432_904e72e0-2558-4548-8ddd-8c6877c23b98 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Sodium Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SODIUM CHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 9 |
| Active Ingredient Units | mg/mL |
| Substance Name | SODIUM CHLORIDE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207310 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65219-0432-85 (65219043285)
| NDC Package Code | 65219-432-85 |
|---|---|
| Billing NDC | 65219043285 |
| Package | 20 BAG in 1 CASE (65219-432-85) / 500 mL in 1 BAG (65219-432-20) |
| Marketing Start Date | 2017-09-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |